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Abstract
Background: Self-control in childhood has been linked to long-term and cascading effects on health, academic,
criminality, wealth and parenting outcomes. Hence it is important to target self-control deficits early in life. Self-
control deficits are a hallmark of Attention Deficit/Hyperactivity Disorder (ADHD). Even after receiving care-as-usual
(CAU) for ADHD, impaired self-control often remains. Pharmacotherapy can be hampered by side-effects, low
adherence and short-term effectiveness. Other limitations of CAU are decreased effectiveness when parents have
ADHD and little effect on parental well-being. Mindfulness-Based Interventions (MBIs) are an emerging non-
pharmacological approach with potential to improve self-control and well-being in both children and parents.
However, there is a lack of sufficiently powered randomised controlled trials (RCTs) to establish their effects in
families with ADHD. This study protocol describes an RCT to investigate the effectiveness of a family MBI as
an add-on to CAU in treatment of youth with ADHD, and is described in accordance with Standard Protocol
Items: Recommendations for Interventional Trials (SPIRIT).
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Methods/design: An RCT will be conducted in N = 100 children (aged 8–16 years) with ADHD and their parents. The
experimental condition will consist of a family MBI (MYmind): 8-week group-based MBI for youth combined with parallel
group-based Mindful Parenting for their parents, as an add-on to CAU. The control condition will consist of CAU-only.
Assessments will take place at baseline, end of treatment (3 months later), 2 and 6 months’ follow-up. Primary outcome
measure will be an ecologically valid assessment of child self-control with the parent-rated Behaviour Rating Inventory of
Executive Function (BRIEF). Secondary child outcome measures will be teacher-rated BRIEF, computerised self-control
tasks and questionnaires on psychological symptoms (e.g. ADHD, symptoms of autism), well-being and mindfulness. For
parental outcomes, secondary measures will be self-rated BRIEF, computerised self-control tasks and questionnaires on
psychological symptoms, well-being and mindful parenting.
Discussion: The proposed RCT will take account of methodological limitations of previous studies on MBIs in
child ADHD populations. The current study will provide valuable information on family MBI as a potential
effective intervention in targeting self-control deficits for youth with ADHD and their parents.
Trial registration: ClinicalTrials.gov NCT03220308. Retrospectively registered 18 July 2017.
Keywords: Self-control, Executive function, Attention, Adolescent, Parents, Mindfulness, ADHD,
Background
Self-control can be seen as an umbrella construct that
bridges concepts from different disciplines (e.g., execu-
tive function, impulse control, attention-regulation,
emotion-regulation, planning, delay of gratification, and
cognitive flexibility) [1, 2]. Poor self-control is an im-
portant feature of psychiatric disorders arising in child-
hood and adolescence, including Attention Deficit/
Hyperactivity Disorder (ADHD), oppositional defiant
disorder (ODD), conduct disorder (CD), mood and
anxiety disorders, substance use disorder, and gambling
[3–5]. Early self-control predicts not only mental and
physical health, but also current and later academic per-
formance, wealth, criminality and parenting [1, 6–8]. For
example, children with poor self-control at preschool
age have been shown to be more likely to have substance
dependence, financial troubles and a criminal record at
age 32 [1]. Therefore, targeting self-control in interven-
tions for youth with deficits in self-control appears of ut-
most importance.
Self-control can be trained, although it is unclear
which interventions are most effective in improving
self-control in youth [9]. Mindfulness-Based Interven-
tions (MBIs) use exercises that train self-control capaci-
ties [10] and are increasingly gaining ground as an
approach to increase self-control in youth [11, 12].
Mindfulness is often defined as the trainable capacity to
pay attention to experiences in the present moment, on
purpose and without judgement [13, 14]. It has been
suggested that MBIs enhance self-regulation through
three interacting processes: enhanced attention control,
improved emotional regulation, and altered self-awareness
(diminished self-referential processing and enhanced body
awareness) [15]. This is supported by an activation likeli-
hood estimation meta-analysis of 21 structural neuroimag-
ing studies in ~ 300 adult (mindfulness) meditation
practitioners, showing that neural correlates of these cog-
nitive processes are altered in meditators compared to
non-meditators with a global medium effect size [16]. In
addition, 78 functional neuroimaging studies were
reviewed in an activation likelihood estimation
meta-analysis with 527 healthy non-clinical adult medita-
tion practitioners who actually meditated during scanning.
The results indicate dissociable brain (de)activation pat-
terns during different styles of meditation, which are con-
gruent with the psychological and behavioural aims of
each practice [17]. If neural mechanisms underlying
self-control can be altered structurally and functionally by
meditation practices, this likely results in effects on behav-
ioural and cognitive measures of self-control as well.
Previous clinical trials show that self-control can be
improved following MBIs in diverse populations. Rando-
mised Controlled Trials (RCTs) show greater improve-
ment after MBIs than active control conditions in
executive functions of adults (undergraduates, N = 80),
adolescents (middle and high school students, N = 489)
and children (4–5 years, N = 60) [18]. A meta-analysis
on neuropsychological outcomes of MBIs in adult popu-
lations (clinical and non-clinical) found preliminary evi-
dence for positive effects on general awareness and
meta-awareness, cognitive flexibility and working mem-
ory [19]. However, evidence was weak for improvement
of attentional control (alerting/sustained attention,
orienting/selective attention and executive attention),
executive function inhibition and mental set shifting. For
youth (5–18 years old), a systematic review of interven-
tions with a focus on yoga-, meditation-, and/or
mindfulness-based techniques found significant effects
of the interventions on attention and executive function-
ing with medium to large effect sizes in five of the thir-
teen included studies. However, study populations
consisted of both non-clinical and clinical populations
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and methodological quality of the studies varied [20]. A
meta-analysis of MBIs with youth found significantly
higher effect sizes for clinical samples than for
non-clinical samples [21]. In addition, an RCT found
that specifically children with poor executive functioning
show improvement in this area based on teacher and
parent reports [22]. Hence, effectiveness of MBIs in in-
creasing self-control may be greater in a more homoge-
neous clinical population with self-control difficulties.
As a consequence, MBIs are increasingly applied as an
approach in the treatment of ADHD in which deficits in
self-control are a central component [23]. ADHD is a com-
mon neurodevelopmental disorder characterised by impair-
ing symptoms of inattention and hyperactivity-impulsivity,
affecting 5–7.5% of all children worldwide [24]. The annual
health care costs and societal ‘costs of illness’ of ADHD in
youth are high and comparable in magnitude to other ser-
ious medical problems (e.g. stroke, asthma in children) and
mental health problems (e.G. major depressive disorder)
[25]. Furthermore, ADHD has a significant impact on
the quality of life of the affected children comparable to
other mental health conditions (e.g. anxiety disorders,
autism spectrum disorders (ASD), mood disorders) and
severe physical disorders (e.g. cerebral palsy, cancer)
[26, 27]. Moreover, quality of life of parents is also
negatively affected by ADHD of their child, for example
in terms of their psychological well-being, personal ful-
filment, family and couple relationships and daily life
activities [28].
Current care-as-usual (CAU) for children with ADHD
consists of psychoeducation, pharmacotherapy and/or
(cognitive-) behavioural treatments [29, 30]. Psychoedu-
cation enhances parents’ knowledge about ADHD and
may enhance engagement in psychopharmacological
treatment [31]. Pharmacotherapy can be effective in re-
ducing core symptoms of ADHD and to a lesser extent
improving other outcomes like quality of life, function-
ing [32], response inhibition, sustained attention and
working memory [33]. However, pharmacotherapy can
be hampered by side effects and low adherence [34–38].
Meta-analyses of (cognitive) behavioural interventions in
the treatment of youth with ADHD show that these can
improve parenting behaviour, increase parents’ sense of
self-worth and reduce child conduct problems. Specific
modules may improve child social skills and academic
functioning [31]. Nevertheless, this review also shows
that behavioural treatment does not reduce observer
rated ADHD symptoms of the child and no support was
found for its effects on parental mental well-being [31,
39]. Moreover, cognitive training of attention and execu-
tive functioning in children with ADHD does not yield
significant improvements in these areas [40]. Another
limitation of both pharmacotherapy and behavioural in-
terventions for ADHD is that treatment is less effective
when parents have ADHD themselves [31, 41]. As
ADHD runs in families and is highly heritable, this is
often the case [42, 43]. In conclusion, CAU for ADHD is
not sufficient for many families and a substantial sub-
group of children with ADHD has remaining symptoms
and impairment [44, 45]. MBIs for children and their
parents are promising in targeting self-control, behav-
ioural symptoms and parental outcomes [46–49].
Previous studies on MBIs as a treatment approach for
youth with ADHD have been reviewed in several publi-
cations. A meta-analysis of studies on pre-post effects
of MBIs on ADHD core symptoms in children and
adults diagnosed with ADHD [50] yields an overall ef-
fect size of d = −.66 for reduction of inattention symp-
toms and d = −.53 for reduction of hyperactivity/
impulsivity symptoms. In a subgroup analysis of the six
included trials in children and adolescents only,
medium effect sizes were calculated for both inatten-
tion (d = −.66) and hyperactivity/impulsivity (d = −.47).
Next to effects on ADHD core symptoms, other clinical
effects in children with an ADHD diagnosis (≤ 18 years)
and their parents were studied in a systematic review
which included a broader range of interventions, i.e.
studies with an intervention focusing on mindfulness
and/or yoga techniques with either parents, children
and/or parents plus children [51]. Eight of the sixteen
studies targeted children only and another eight studies
investigated a family-based intervention. Positive results
were found for improvements after meditation-based
interventions in parent-reports of child functioning,
parent and/or teacher-reports of child internalising/
externalising behaviour, parental ADHD symptoms,
parental satisfaction, parent–child relationships and
parental happiness, but not in child self-reported happi-
ness. Mixed or limited evidence was found for improve-
ments in child ADHD symptoms, child self-esteem,
child social functioning, child academic performance,
child self-report of functioning, child-report of interna-
lising/externalising symptoms and parental stress and
over reactivity of the parent. Finally, larger effect sizes
in child outcomes, lower incidence of poorer outcomes,
and more favourable outcomes for parents resulted
from trials with family-based interventions compared
to child-only interventions. In conclusion, previous re-
search on the effectiveness of MBIs in the treatment of
youth with ADHD shows these are feasible interven-
tions for ADHD with potential benefits across a broad
range of outcomes including ADHD symptoms,
well-being and outcomes for parents. However, the re-
sults above should be interpreted with caution due to
limited methodological quality of the reviewed studies.
It is of note that none of the systematic reviews on
MBIs for youth with ADHD focused on self-control in
particular.
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A few clinical trials looked at effects of MBIs on
self-control as assessed with neurocognitive tests and/or
with questionnaires in youth with ADHD. In a first RCT,
comparing a family MBI with a waitlist control group in
children with ADHD aged five to seven years (N = 100)
and their parents, significantly greater improvement in
the family MBI group compared to control group was
found for child executive attention (conflict monitor-
ing)(d = .41) [52]. This result is in line with a
quasi-experimental trial on neurocognitive task per-
formance following an MBI in adolescents (N = 8)
and adults (N = 24) with ADHD, which also found
significant improvements for measures of executive
attention. In addition, significant effects were found
for set-shifting [53]. A pilot pre-post-intervention
study with a family MBI in children aged eight to
twelve years (n = 11) found significant improvement
with large effect sizes on objective attention tests, but
not on parent ratings of self-control on the Behaviour
Rating Inventory of Executive Function (BRIEF) [54].
In contrast, in a quasi-experimental trial with ten ad-
olescents (aged 11–15 years) following a family MBI,
self-control assessed with the BRIEF improved signifi-
cantly at 8-weeks follow-up, but only according to
father reports and not mother reports [55]. For youth
with ADHD, no RCT has been published on effects
of MBIs on ecologically valid questionnaire ratings of
self-control (e.g. BRIEF). In adults with ADHD, a ran-
domised waitlist controlled MBI trial (N = 20)
resulted in significant group differences at the end of
treatment favouring the MBI group on self-reported
self-control (assessed in the laboratory and with eco-
logical momentary assessment) and clinician rated
self-control with large effect sizes. In contrast, no sig-
nificant improvement was observed with the objective
self-control tasks [56]. In another waitlist RCT on an
MBI in adults with ADHD (N = 103), self-control as
assessed with the BRIEF improved with a large effect
size (d = .93) as well [57]. Furthermore, in a rando-
mised CAU controlled MBI trial in 120 adults with
ADHD, improvement on the BRIEF over time after
MBI + CAU compared with CAU only was found,
resulting in an effect size of d = .49 at 6-month
follow-up [58]. In summary, implementing MBIs in
the treatment of youth with ADHD to improve
self-control is promising. Although there are prelimin-
ary positive results, the existing evidence in youth is
insufficient due to a lack of studies with good meth-
odological quality. RCTs with sufficient power are
needed.
The current protocol describes an RCT comparing an
8-week family MBI for youth with ADHD and their par-
ents (MYmind) in addition to CAU with continuation of
CAU only. Participating children will have an ADHD
diagnosis and comorbidities will be allowed (including
ASD). The primary, secondary and tertiary aims corres-
pond to the primary, secondary and tertiary measures
that will be used in this study. The primary aim is to in-
vestigate the effectiveness of a family MBI in improving
self-control of youth with ADHD, as assessed with
ecologically valid parent-ratings (BRIEF-P, primary out-
come). Different definitions are used in literature on
self-control, some take a broad approach, other narrow,
and opinions vary on what self-control comprises. We
take a broad view on self-control in that it entails
self-regulation of behaviour, emotion, cognition and at-
tention. Given the moderate convergent validity of neu-
rocognitive tests of self-control, we prefer
ecologically-valid questionnaire ratings of self-control
over neurocognitive tests [2]. The predictive validity of
behavioural questionnaire ratings of self-control on
clinically and societally relevant objective outcomes
even decades later (e.g. months unemployed, single
parenthood, criminal conviction) has been docu-
mented [1, 59]. The secondary aim is to examine the ef-
fects of family MBI on child self-control as assessed with
teacher-ratings (BRIEF-T) and objective computerised
tasks and on psychological symptoms (e.g. ADHD symp-
toms, symptoms of ASD, brooding), well-being and mind-
fulness of the children (secondary outcome measures for
children). In addition, we aim to examine effects of family
MBI on parental self-control as assessed with ecologically
valid self-ratings (BRIEF-A) and objective computerised
tasks and on psychological symptoms, well-being and
mindful parenting of the parents (secondary outcome
measures for parents). Our tertiary aim is to look at the ef-
fects of family MBI on some exploratory measures such as
mind-wandering. Finally, child saliva samples will be col-
lected for (epi)genetic research and qualitative data will be
collected to explore effects that are not captured with
quantitative assessments and to explore facilitators and
barriers of family MBI for youth with ADHD and their
parents.
Methods/design
Study design
This is a parallel group RCT in which all participants
with ADHD receive CAU. Randomisation will assign
children with ADHD and their parents to either a family
MBI (plus continuation of CAU) or to the control condi-
tion (continuation of CAU) with a 1:1 ratio.
Participants
The study population will consist of children aged 8–
16 years with an ADHD diagnosis and at least one of
their parents. The families will be recruited through the
outpatient clinic of Karakter, an institute for child and
adolescent psychiatry. Recruitment will take place at
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three different Karakter locations in the central eastern
part of the Netherlands, namely Nijmegen, Arnhem and
Ede (see also the clinical trial registration). In addition,
families will be recruited by media advertisements.
Eligibility criteria
We will include families who meet the following cri-
teria: a) child is 8–16 years old and in the third grade
of primary school or higher; b) child has a primary
diagnosis of ADHD according to the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV or
DSM-5) system [60, 61] and confirmed by a structured
interview (see Assessments section); c) child receives
CAU for ADHD and has remaining ADHD symptoms
(average score > 1.0 on the investigator-rated DSM-5
items from the Conners’ ADHD rating scale [62]); d)
ADHD medication dose of child is stable, at least two
weeks prior to baseline, or an informed decision is
made on not taking ADHD medication; e) at least one
parent is willing to participate. Exclusion criteria are a)
psychosis, bipolar illness, active suicidality, untreated
posttraumatic stress disorder or substance use disorder
of the child that impedes functioning; b) psychosis, bi-
polar disorder, active suicidality, untreated posttrau-
matic stress disorder or substance use disorder of the
parent that impedes functioning; c) child and/or par-
ticipating parents have an estimated Intelligence Quo-
tient (IQ) < 80; d) child and/or participating parents do
not have adequate mastery of Dutch language; e) child
and/or participating parents have participated in an > =
8-week mindfulness programme in the past year or ever
in a Mindful Parenting training; f ) child or parents par-
ticipate in another intervention study.
Intervention
Family MBI (MYmind)
We will use the MYmind course [63], a standardised,
highly-structured protocol developed to target the spe-
cific difficulties that children with ADHD and their par-
ents may confront when meditating. As self-control
problems in regulating attention, impulses and motor
activity are core issues of children with ADHD, the
course is designed around these difficulties. The aim of
MYmind is to teach children to meditate and to practice
non-reactivity, that is, awareness of their impulses but
not following them automatically. The course for the
parents focuses on their role as a parent, through
teaching them mindful parenting (e.g., to help guide
their child with the meditations, practice non-reactive
parenting and mindful communication with the child),
but also directly addresses parents’ own self-control
and behaviour.
MYmind consists of eight weekly 90-min group ses-
sions for children (groups of approximately 5–8), and
parallel group sessions for their parents of equal length
and duration. The child and parent sessions take place
in separate rooms, with the exception of sessions 1, 5
and 8, where part of the session is together in the same
room. In the sessions (playful) mindfulness exercises are
done and education is given around the following
themes, one per session: 1) Beginners’ mind, 2) Home in
our body, 3) The breath, 4) Distractors!, 5) Stress, 6)
High way, walking way, 7) Acceptance & autonomy, and
8) The future. Both children and parents receive daily
homework during the eight weeks of training (15 min
for child and 30–45 min for parent, 6 days/week). The-
ory and exercises are described in a workbook that both
children and parents receive together with audio-files to
guide the mindfulness exercises. As children with
ADHD may have motivational problems, a reward sys-
tem is incorporated in the course for the children to
enhance motivation to practice in the sessions and at
home. The 8-week course is followed by eight weeks of
home self-practice, and a single joint child-parent
90-min booster session. In the booster session, partici-
pants share experiences of the mindfulness practice in
the last eight weeks where they did not have the support
of the group training, rehearse certain practices in order
to remind the families of the possible joys and benefits
of mindfulness practice, and are encouraged to think
about how to implement mindfulness in their lives and
to renew their intentions. Participants who attend four
or more sessions will be considered as ‘completers’.
The first trial on an MBI for children combined with
Mindful Parenting was conducted by Bögels et al. (2008)
[64], which resulted in the MYmind training. Since then,
several non-randomised pilot studies have been con-
ducted with the MYmind training in child and adoles-
cent samples with ADHD [54, 55, 65–67] and with ASD
[68, 69]. Findings are promising and show that the
MYmind training is feasible and acceptable [70].
Mindfulness teachers
Mindfulness teachers will have to be experienced and
meet quality criteria for category 1 from the VMBN
(Association of mindfulness-based teachers in the
Netherlands and Flanders), which are in accordance
with the ‘UK Mindfulness-Based Teacher Trainer Net-
work’ [71]. The criteria for category 1 of the VMBN
include a college or university degree; > = three years
of regular meditation experience; > = one 10-day
retreat or two 5-day retreats in the past four years;
having participated in a Mindfulness-Based Stress Re-
duction (MBSR) [72] or Mindfulness-Based Cognitive
Therapy (MBCT) [73] course; > = 150 h of education
in MBSR/MBCT (skills training in giving formal and
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informal practices, theory and practice of
psycho-education and inquiry, theoretical foundation,
supervision, reflection report, adequate use of course
materials and experience in giving training); > = seven
days in-service training per two years; giving > = two
MBSR/MBCT courses per two years. In addition, for
the current study, mindfulness teachers will be
trained thoroughly in the administration of the
MYmind protocol by following a 5½-day advanced
teacher training in MYmind given by its developer
(SB). Following an advanced teacher training in
MYmind also gives teachers access to the course ma-
terials (i.e. workbooks and audio files) for the partici-
pants. During the trial, the mindfulness teachers will
be supervised by SB who has extensive expertise and
experience working with the intervention delivered in
this proposal. In the child-group there will be a
mindfulness co-teacher, who will have experience with
children with ADHD, in addition to the mindfulness
teacher. All sessions during the 8-week training will
be videotaped for treatment integrity purposes. Mind-
fulness teacher competency will be assessed on the
Teaching Assessment Criteria (MBI:TAC; [74, 75]) by
experienced mindfulness teachers using a random se-
lection of the videotapes on the Teaching Assessment
Criteria (MBI:TAC [74, 75]).
CAU
According to the Dutch Multidisciplinary guidelines for
the diagnosis and treatment of ADHD [76], CAU for chil-
dren aged 8–16 years consists of psycho-education and
the prescription of medication approved for ADHD and/
or evidence-based parent and/or teacher-administered be-
haviour therapy, preferably both medication and behav-
iour therapy. First-line option for medication is a
psychostimulant, second-line options are atomoxetine or
alpha-2 presynaptic agonists. Participants in the
CAU-group will be informed that it is not allowed to par-
ticipate in a mindfulness programme until the 2-month
follow-up assessments of the study.
Expectancy, satisfaction, compliance and healthcare
consumption
For family MBI and CAU condition, credibility and ex-
pectancy of clinical outcome will be evaluated with the
parent-rated 6-item Credibility/Expectancy Question-
naire (CEQ, translation to Dutch by the authors for this
study) [77]. The CEQ shows a good internal consistency
and test-retest reliability [77]. Satisfaction with family
MBI/CAU will be assessed in parents and children at
end of treatment, 2- and 6-month follow-up. Parental
and child compliance with the mindfulness practices,
and child adherence with any ADHD medication, will be
assessed in the parents at the same three time points.
Type and dose of possible ADHD-medication and other
medication will be assessed at all time points for parent
and child. At baseline parents will report which treat-
ments for ADHD the child received prior to study par-
ticipation. In addition, child healthcare consumption
between assessments will be assessed with a 30-item
adapted version of the parent-rated Trimbos and iMTA
questionnaire on Costs associated with Psychiatric ill-
ness (TiC-P) [78] at end of treatment and both
follow-up time points. Parental healthcare consumption
during the whole study period will be assessed with the
46-item self-rated TiC-P at 6-month follow-up. The
TiC-P is a valid questionnaire with a sufficient to high
test-retest validity (ICC > .6) [79].
Assessments
Descriptives
Clinical ADHD diagnosis will be confirmed using a
structured psychiatric interview (Schedule for Affective
Disorders and Schizophrenia for School-Age
Children-Present and Lifetime Version; K-SADS-PL)
[80], adapted to DSM-5 and administered to a parent by
a trained researcher. The focus of the interview will be
on the behaviour of the child off medication in the past
half year. Further, parents will be screened for the pres-
ence of adult psychiatric disorders, using the 10-item
Kessler Psychological Distress Scale (K10) [81]. For those
with elevated scores (25 or higher) a diagnostic interview
(Mini-International Neuropsychiatric Interview; MINI)
[82] will be administered to establish axis-I disorders by
a trained researcher. In case no valid IQ test results of
participants are available, full-scale IQ will be estimated
by two subtests of the Wechsler Intelligence Scale for
Children-Third Edition (WISC-III) [83] or Wechsler
Adult Intelligence Scale-Third Edition (WAIS-III) [84]:
Vocabulary and Block Design. These subtests together
are known to correlate between .88–.91 with the
Full-scale IQ [85, 86]. Standardised questionnaires com-
pleted by parents as part of routine intake procedures at
Karakter will give us a wide range of additional back-
ground information on variables such as age, gender,
medical/medication history, ethnicity, family-structure
and socioeconomic status. Some additional participant
characteristics will be collected at baseline as there
might be changes in family-structure or socioeconomic
status between intake at Karakter and study participa-
tion. The Pubertal/Physical Development Scale (PDS)
[87] will be used to assess the pubertal developmental
stage of the child at baseline and 6-month follow-up.
Primary outcome measure
Parent-rated child self-control To measure
self-control of the child, we will use the parent-rated
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version of the BRIEF [88], which assesses real-life
self-control skills across situations and is used in clinical
and research settings for ADHD. The questionnaire con-
sists of 75 items with a 3-point rating scale ranging from
1 (never) to 3 (often) with higher scores indicating more
problems in executive functioning. The BRIEF gives rise
to a global executive composite score as well as two
broad indexes (Behavioural Regulation and Metacogni-
tion) and eight subscales (Inhibit, Shift, Emotional Con-
trol, Initiate, Working Memory, Plan/Organise,
Organisation of Materials, and Monitor). The internal
consistency of the Dutch version is sufficient when ad-
ministered to adolescents with ADHD (Cronbach’s α co-
efficients ranging from .69 to .95) [55]. Test-retest
reliability is high with intra-class correlations of ≥.73.
The BRIEF demonstrates good convergent validity [88].
Secondary outcome measures for children
Teacher-rated child self-control Child self-control will
also be assessed using teacher-ratings on the BRIEF-T
[88]. Teachers have the advantage to be able to evaluate
the child’s behaviour in the context of their peers’ behav-
iour and of the normative range, and are blinded to
exactly which intervention is provided to the child at
home and/or in the clinic [89]. The BRIEF-T consists of
75 items with the same 3-point rating scale and struc-
ture as the parent form. The Dutch version shows a
good internal consistency, with Cronbach’s α coefficients
ranging from .88 to .98, and a high test-retest reliability
(ICC = .77 for the global executive composite score) [88].
Computerised tasks of child self-control Logan’s Stop
Signal task will be used to measure motor inhibition
[90, 91]. In this task, participants are presented with
go-trials which consist of the presentation of a stimulus
(i.e. either the letter O or the letter X) and are
instructed to press the corresponding response button
as quickly and accurately as possible. In 25% of the tri-
als, at random, the go-trial is followed by an auditory
stop-signal (i.e. a tone). In those trials, participants are
required to withhold their response. The delay between
the go and the stop signal is varied using a dynamic
tracking algorithm, such that an average person has a
50% chance of correctly withholding their response at a
stop-trial. The two main dependent behavioural mea-
sures will be the percentage of errors and the Stop
Signal Reaction Time (SSRT), which is calculated by
subtracting the Mean Delay from the Mean Correct Re-
action Time [90]. Secondary behavioural outcome mea-
sures will be reaction time variability and speed
accuracy trade off [92]. The Stop Signal task shows an
adequate test-retest reliability when administered to
children with ADHD (ICC = .72 for the SSRT) [91].
Temporal discounting refers to the decrease of sub-
jective reward value as a function of increasing delay
[93]. In the Temporal Discounting task that will be used
in this study [94, 95] participants are asked to choose
between a smaller immediate reward (i.e. one, two, three
of four eurocents) and a larger delayed reward (i.e. five
eurocents) during forty trials. Choices are visually repre-
sented by two airplanes on a computer screen. Delays
are represented by the “height” at which the planes are
flying, and vary between five and sixty seconds. Partici-
pants choose the preferred plane which results in earn-
ing the chosen amount, immediately or after the
appropriate delay. A maximum of two euros can be
earned. The computer task will be followed by a debrief-
ing on the child’s choices and emotions regarding every
delay interval using the Self-Assessment Manikin. This
measure is shown to be a reliable, non-verbal method
for assessing a person’s emotional reaction in response
to a certain event or stimulus [96]. Outcome measure
will be the subjective reward value, defined as the mag-
nitude of the smaller immediate reward that leads to
indifference of the participant towards the larger delayed
reward [93]. At this point, the participant shows no clear
preference for one of the rewards, either the delayed or
the immediate one. The real Temporal Discounting task
(with actual money and delays) has a clear advantage
compared to hypothetical tasks in terms of ecological
validity [97] and is proven useful in assessing individual
differences in children versus adolescents [94] and indi-
viduals with less and more hyperactivity/impulsivity
symptoms [98].
The Probabilistic Reversal Learning task will be used
to determine the cognitive ability to adapt behaviour
according to changes in stimulus-reward contingencies,
also known as cognitive flexibility [99]. An experimental
study has shown impaired reversal learning to reflect re-
duced inhibitory control of affective responses, and
therefore might be related to deficits in self-control
[100]. In the Probabilistic Reversal Learning task partici-
pants repeatedly choose between two visual stimuli dur-
ing eighty trials, followed by rewarding or punishing
auditory feedback. In 80% of the trials, the choice is
followed by actual feedback (i.e. rewarding tone with
correct response and punishing tone with incorrect
response) and in 20% by misleading feedback. The
stimulus-outcome contingencies reverse unannounced
after forty trials, resulting in the previous mostly
rewarded stimulus now being mostly punished and vice
versa. Subjects are instructed that the contingencies may
change, but do not know when or how often. Thus, the
difficulty in performing the task comes from the need to
integrate feedback over a number of trials because nega-
tive feedback may either be a probabilistic punishment
or signal a true reversal. Outcome measures will be
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Ratio Win-Stay (the number of times the participant re-
peats their choice following a rewarded trial, divided by
the total times the participant repeats their choice), Ra-
tio Lose-Shift (the number of times the participant shifts
response following a punished trial, divided by the total
times the participant shifts choices) and perseverative er-
rors (two or more consecutive error responses during
the reversal phase) [99]. The Probabilistic Reversal Learn-
ing task is a well-defined and ecological instrument which
is widely used measuring cognitive flexibility in children
[101] and adolescents [102]. Neurocognitive test instruc-
tions to children can be found in Additional file 1.
Child psychological symptoms Externalising and
internalising problem behaviours of the child will be
assessed through parent- and teacher-ratings on the
Conners’ Parent/Teacher Rating Scales-Revised: Long
(CPRS-R:L [62]/CTRS-R:L [103]). We will use the
subscales DSM-IV Inattentive Symptoms, DSM-IV
Hyperactivity-Impulsive Symptoms, Oppositional,
Anxious-Shy, Social problems and the Emotional La-
bility Index, resulting in questionnaires containing 44
(CPRS) and 37 items (CTRS). Items are scored on a
4-point rating scale ranging from 0 (not true at all)
to 3 (very much true) with higher scores reflecting
more symptoms. Both forms of the American version
have a good internal consistency for all named
subscales (Cronbach’s α coefficient ranging from .80
to .94) except the Emotional Lability Index, which is
sufficient (Cronbach’s α coefficient ranging from .72
to .80) [103].
Symptoms of ASD will be assessed with the Social Re-
sponsiveness Scale (SRS) [104, 105] rated by parent and
teacher. The 65 items can be organised into five subscales
(i.e. Social Awareness, Social Cognition, Social Communi-
cation, Social Motivation, and Restricted Interests and Re-
petitive Behaviour) and two DSM-5 subscales (i.e. Social
Communication and Interaction, and Restricted Interests
and Repetitive Behaviour). Items are rated on a 4-point
rating scale ranging from 1 (not true) to 4 (almost always
true) with higher scores reflecting less social responsive-
ness. The Dutch version has a good internal consistency
for both the parent- and teacher-form with Cronbach’s α
coefficients of .92 and higher [106].
Brooding will be assessed using the self-report sub-
scale of the Ruminative Response Scale (RRS; items
reformulated by the authors for children from age 8)
[107, 108]. Items are scored on a 4-point rating scale
ranging from 1 (almost never) to 4 (almost always)
with higher scores reflecting more brooding in re-
sponse to sadness. The internal consistency of the
American Brooding subscale is good (α = .80) when
administered to adolescents [109].
Child well-being We will use parents report on their
child’s quality of life using the 11-item KIDSCREEN-10
[110]. Items are scored on a 5-point rating scale ranging
from 1 (never) to 5 (always) with higher scores reflecting
a higher health related quality of life. The internal
consistency based on ten items is adequate (α = .78)
[111].
Child mindfulness Mindfulness skills will be assessed
using self-report on the Child and Adolescent Mindful-
ness Measure (CAMM) [112, 113]. The CAMM consists
of ten items that are scored on a 5-point rating scale
ranging from 0 (never true) to 4 (always true) with lower
scores reflecting better mindfulness skills. Internal
consistency for the Dutch version was reasonable when
administered to children (α = .71) and good for adoles-
cents (α = .80) [112].
Secondary outcome measures for parents
Self-rated parental self-control Adult versions of the
self-control measures for children will be administered
to parents. The BRIEF-A [114] is a 75-item self-report
questionnaire comparable to the child version in rating
scale and structure, but with slightly different subscales
(i.e. Inhibit, Shift, Emotional Control, Self-Monitor, Initi-
ate, Working Memory, Plan/Organise, Task Monitor and
Organisation of Materials). The Dutch version shows a
good internal consistency for the global executive com-
posite score and both indexes (Cronbach’s α coefficient
ranging from .92 to .96) and sufficient internal
consistency for all subscales [114].
Computerised tasks of parental self-control The par-
ents’ version of the Stop Signal task and the Probabilistic
Reversal Learning task will be identical to those de-
scribed for children. The Stop Signal task shows an ad-
equate test-retest reliability when administered to adults
without a DSM-IV diagnosis in the past year (r = .65 for
the SSRT) [115]. The Probabilistic Reversal Learning
task shows adequate results when administered to adults
with schizophrenia (ICC ranging from .49 to .68) [116].
As the Temporal Discounting task that will be used
for children is not appropriate for use in adults, a hypo-
thetical Temporal Discounting task will be administered
to the parents. Participants make a series of choices re-
garding fictional amounts of money (rewards), ranging
between one and hundred euros, available now versus
after a specified delay interval (i.e. one month, one year,
five years, ten years). Instructions are presented on the
screen and are identical to those used by R. M. Hurst, H.
O. Kepley, M. K. McCalla and M. K. Livermore [117].
For each trial, two variable rewards are presented in a
random order, to increase the likelihood that the
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decisions are based on the amount in the individual
trial and not on the previous trial. The participant’s
score on the different delay intervals is the reward
value where they switch between taking the delayed
reward to taking the immediate one. The hypothetic-
ally Temporal Discounting task is widely used in vari-
ous studies [97] and shows good internal consistency
(α = .89) when administered to adults with and with-
out self-reported ADHD [117]. Neurocognitive test in-
structions to parents can be found in Additional file 1.
Parental psychological symptoms Symptoms of
ADHD will be assessed using self-report on the Dutch
version of the ADHD DSM-IV rating scale [118], which
consists of 26 items concerning behaviour in the last
two weeks (23 items) and childhood (three items). The
latter three items are useful for estimating ADHD diag-
nosis, as onset of ADHD symptoms needs to be before
the age of twelve according to the DSM-5. Items are
scored on a 4-point rating scale ranging from 0 (never
or seldom) to 3 (very often) with higher scores indicat-
ing more ADHD traits. The internal consistency is high
for the Inattentiveness dimension (α = .83) and
adequate for both the Hyperactivity (α = .75) and Im-
pulsivity dimension (α = .72) [118].
Symptoms of ASD will be assessed using the self-rated
10-item Short Autism-Spectrum Quotient (AQ-10) [119,
120]. Each item is rated on a 4-point rating scale (1 = def-
initely agree, 2 = slightly agree, 3 = slightly disagree, 4
= definitely disagree) with higher scores indicating more
symptoms of ASD. The internal consistency is good for
the English 10-item version (α > .85) [120].
Symptoms of depression, anxiety and stress will be
assessed using the self-rated 21-item Depression Anx-
iety Stress Scale (DASS-21) [121, 122] rated on a
4-point rating scale ranging from 0 (did not apply to
me at all) to 3 (applied to me very much of most of
the time). Higher scores reflect more symptoms of de-
pression, anxiety and/or stress. All subscales of the
Dutch version show a good internal consistency with
Cronbach’s α coefficient ranging from .85 to .94 for
students and a clinical sample of adults with an anx-
iety disorder and/or depression [122].
Brooding will be assessed using the Brooding subscale
of the self-rated RRS [107, 108] containing five items
that are rated on a 4-point rating scale ranging from 1
(almost never) to 4 (almost always). Higher scores indi-
cate more brooding in response to sadness. The internal
consistency of the Dutch Brooding subscale is sufficient
(α = .78) when administered to adults [108].
Parental well-being Quality of life will be assessed
using the self-rated 5-item World Health
Organization-Five Well-Being Index (WHO-5) [123].
Each item is scored on a 6-point rating scale ranging
from 5 (all the time) to 0 (not at all). Higher scores re-
flect higher psychological well-being. The WHO-5
shows an adequate validity as an outcome measure in
clinical controlled trials, sensitive for assessing change
[124].
Emotional, psychological and social well-being will be
assessed using self-report on the 14-item Mental Health
Continuum-Short Form (MHC-SF) [125]. Each item is
scored on a 6-point rating scale ranging from 0 (never)
to 5 (every day) with higher scores indicating more posi-
tive mental health. The Dutch version shows high in-
ternal consistency for the total MHC-SF score (α = .89)
and the two subscales Emotional and Psychological
Well-Being (both α = .83), and adequate for the third
subscale Social Well-Being (α = .74) [125].
Mindful parenting We will use self-ratings on the
31-item Interpersonal Mindfulness in Parenting scale
(IM-P) [126, 127] assessing 1) Listening with Full Atten-
tion; 2) Compassion for the Child; 3) Non-judgmental
Acceptance of Parental Functioning; 4) Emotional Non-
reactivity in Parenting; 5) Emotional Awareness of the
Child and 6) Emotional Awareness of Self. Items are
scored on a 5-point rating scale (1 = never true, 2 = rarely
true, 3 = sometimes true, 4 = often true, 5 = always true)
with higher scores reflecting more mindful parenting.
The Dutch version of the IM-P shows a good internal
consistency based on 29 items (α = .89) [126].
Tertiary measures for children
Self-rated We will use the 8-item subscale Body Aware-
ness of the Body Experience Questionnaire for Children
(BEQC) as a tertiary measure, which shows an adequate
internal consistency for the Dutch version (α = .71)
[128]. Sensory-processing sensitivity will be assessed
using the 12-item Highly Sensitive Child Scale (HSCS).
The HSCS shows an adequate internal consistency (α
= .79) [129]. For children aged eleven and older we will
use the 24-item Inventory of Callous-Unemotional
Traits (ICU) assessing uncaring, callousness and unemo-
tional traits. The Dutch version shows a good internal
consistency (α = .89) [130]. Self-compassion will be
assessed by using one item per subscale of the
Self-Compassion Scale [131] with the highest factor
loading [132]. This resulted in six exploratory items
which were reformulated by the authors for children.
Mind-wandering will be assessed using an exploratory
questionnaire (items developed by JB for this study,
2015) containing three items (e.g. “When you are busy
with schoolwork, a task or a chore, do you notice that
you are daydreaming?”).
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Parent-rated The 18-item DSM-IV-based Strengths and
Weakness of ADHD Symptoms and Normal Behaviour
(SWAN) [133] will be used to assess ADHD traits (in-
attentiveness and hyperactivity-impulsivity). The Dutch
version of the SWAN shows a good internal consistency
(α > .87) when administered to parents (α = .88) [134]
and will be included as it provides good resolution
across the full range of continuous ADHD traits, thereby
potentially providing additional information to the Con-
ners’ Rating Scales [135]. Neuroticism, as a covariate for
the HSCS, will be assessed by administering the 5-item
Big Five questionnaire [136]. Sleeping habits will be
assessed using the 5-item Sleep Questionnaire used in
standard clinical care assessing problems with sleeping
in, sleeping through and total amount of sleep compared
to children of the same age.
Teacher-rated The above described 18-item SWAN
[133] will be administered to teachers, also showing a high
internal consistency for the Dutch version (α = .91) [134].
Tasks Reading speed and accuracy will be assessed with
the Dutch One Minute Reading Test; a test of word de-
coding, in which children are instructed to read as many
words from a list as possible within one minute. The test
shows a good test-retest reliability with high correlations
ranging from .80 to .92 [137].
Tertiary measures for parents
Self-rated The 12-item Highly Sensitive Person Scale
(HSPS) will be administered to parents assessing
sensory-processing sensitivity, showing a good internal
consistency (α = .89) when administered to adults [136].
Neuroticism, as a covariate for the HSPS, will be
assessed by administering the 5-item Big Five question-
naire [136]. For the six subscales of the Self-Compassion
Scale, the item that correlates the most with the total
scale will be selected to create a 6-item questionnaire to
explore self-compassion [132].
Qualitative research
Qualitative interviews with families and mindfulness
teachers will be conducted after the family MBI, with
the aim to capture the richness and heterogeneity of ex-
periences of families with ADHD potentially not tapped
by the quantitative assessments, and to facilitate adapta-
tions to the MYmind protocol based on participant and
mindfulness teacher experience. Purposive sampling will
be used to include a subset of families with different
backgrounds, age groups, gender and drop-outs will also
be interviewed. Data will be generated until saturation is
reached. The interviews are semi-structured using a
topic guide focusing on two main topics: 1) facilitators
and barriers to participating in family MBI training; and
2) effects of family MBI on parent, child and
parent-child interactions. Interviews will be conducted
separately with parent, child and mindfulness teachers.
All interviews will be audio recorded, transcribed verba-
tim and analysed in the Atlas.ti software using Grounded
Theory [138]. Analysis will be performed by a team of
researchers to ensure no data get lost. Essential aspects
of qualitative research concerning relevant participant
selection, appropriate data collection methods, compre-
hensive data collection process and data analysis will be
followed [139].
Biological assessments
Studying (epi)genetic factors alongside environmental
factors in relation to family MBI can help understand
the biological basis of family MBI. Five saliva samples
will be drawn from children for DNA and RNA isolation
and assessment of biomarkers: one OG-500 DNA at
baseline for genotyping of DNA; one Oragene OG-575
DNA at baseline and one at end of treatment for methy-
lomic profiling of CpG DNA sequences; and one Ora-
gene RE-100 RNA at baseline and one at end of
treatment for profiling of transcriptomics (mRNA),
microRNA expression and epigenomic profiling. The
collection of saliva during end of treatment will be
scheduled during the same time of the day as the collec-
tion at baseline within participants to account for hor-
monal fluctuations. Children will be asked to refrain
from food and drinks (except water) and cigarettes thirty
minutes before collection. Samples will be processed
under barcode in a validated and well-controlled pipeline
designed to process samples for clinical use. The mater-
ial of biological nature will be stored at − 20 or − 80 °C
(as appropriate; RE-100 RNA vials to be stored at − 80 °
C to minimise any RNA degradation). Data will be
stored in an automated, validated laboratory information
system (Labvantage: www.labvantage.com/).
Procedure and treatment allocation
Recruitment will take place within the outpatient clinics
of Karakter through screening by the researchers of cur-
rently treated patients or through referral by the psych-
iatrist. In addition, recruitment will take place via media
advertisement (e.g. flyers and website). In case there are
no contra-indications (i.e. exclusion criteria, crisis situ-
ation or family does not want to be approached for
scientific research), families will be contacted by phone
to inform them about the study and to establish whether
they meet the inclusion criteria. Next, information
letters will be sent to parent and child via e-mail. Fam-
ilies will have a minimum of two weeks to consider par-
ticipation. Families willing to participate will then be
sent forms of informed consent in the post: parental
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consent of child participation, parental consent of own
participation, child consent (age > =12 years) of own par-
ticipation. Participants not referred by Karakter will also
give consent to request medical data from the institute/
clinician who diagnosed ADHD. The participants will be
randomised after completion of the informed consent
forms. In case families withdraw consent before the
baseline assessments, randomisation will be undone and
participants can be replaced, in order not to let
non-participants imbalance the treatment groups for the
primary analyses. School teachers and general practi-
tioners of included participants will be informed about
the study via telephone, email and/or postal letter. The
school teachers will be requested not to ask the family
about treatment allocation to keep them ‘blinded’. Like-
wise, the participants will be requested not to speak
about treatment allocation to the school teachers.
Assessments will take place at baseline (T0), end of
treatment (T1), two (T2) and six (T3) months after end
of treatment. For the family MBI condition, T0 will be
scheduled in the two weeks prior to the start of the
intervention and T1 in the two weeks after the 8th ses-
sion of the MYmind training. The booster session will
be followed by the first follow-up assessments (T2)
which will be two months after T1 and the second
follow-up assessments (T3) will be scheduled half a year
after T1. Intervals between assessments will be kept
similar for the family MBI and CAU condition. For base-
line, end of treatment and 6-month follow-up assess-
ments, participants will be invited to a location of
Karakter. Assessments will be conducted by a researcher
or research assistant. Participants will be asked to inter-
rupt ADHD medication intake 48 h prior to these
assessments. For the 2-month follow-up assessments,
both parent and child will receive an invitation to
complete questionnaires online (not at Karakter). School
teachers will be asked to complete all questionnaires on-
line at baseline, end of treatment and 2-month
follow-up. See Table 1 for which assessments for chil-
dren will be taken at which time points and Table 2 for
assessments for parents and time points. Further, see
Fig. 1 for a flowchart on recruitment and the study
procedure.
Sample size
Power calculation
Power analyses are based on the primary hypothesis that
family MBI, relative to control, will lead to improvement
in self-control (as measured by the BRIEF) at end of
treatment. The BRIEF has shown modest to large effect
sizes in MBI studies for clinical samples, including bipo-
lar disorder [140][Cohen’s d effect sizes from 0.08–1.33
on self-report BRIEF] and adult ADHD [57][Cohen’s d
effect size from 0.43 to 0.93 on self-report BRIEF];
Table 1 Assessments for children and time points
Assessments for children Time points
Descriptives
Demographics T0
WISC-III (Vocabulary and Block Design) T0
Investigator-rated K-SADS-PL T0
Self-rated PDS T0 T3
Primary outcome measure
Parent-rated child self-control
BRIEF-P T0 T1 T2 T3
Secondary outcome measures
Teacher-rated self-control
BRIEF-T T0 T1 T2
Computerised tasks of self-control T0 T1 T3
Psychological symptoms
Parent-rated CPRS-L:R (subscales DSM-IV inattentive
symptoms, DSM-IV hyperactivity-impulsive symptoms,
oppositional, anxious-shy, social problems, emotional
lability index)
T0 T1 T2 T3
Teacher-rated CTRS-L:R (subscales DSM-IV inattentive
symptoms, DSM-IV hyperactivity-impulsive symptoms,
oppositional, anxious-shy, social problems, emotional
lability index)
T0 T1 T2
Parent-rated SRS T0 T1 T3
Teacher-rated SRS T0 T1
Self-rated RRS (Brooding) T0 T1 T3
Well-being
Parent-rated KIDSCREEN-11 T0 T1 T3
Mindfulness
Self-rated CAMM T0 T1 T2 T3
Tertiary measures
Self-rated
BEQC T0 T1 T3
HSCP T0
ICU (ages 11+) T0 T1
Self-compassion (exploratory items) T0 T1 T3
Mind-wandering (exploratory items) T0 T1 T2 T3
Parent-rated
SWAN (optional) T0 T1 T3
Neuroticism (covariate for HSCP) T0
Sleeping habits T0 T1 T3
Teacher-rated
SWAN T0 T1
Tasks
One Minute Reading Test T0 T1 T3
Saliva collection T0 T1
T0 baseline, T1 end of treatment, T2 2-month follow-up, and T3 6-month follow-up, WISC-
III Wechsler Child Intelligence Scale-Third Edition, K-SADS-P Schedule for Affective
Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, PDS
Pubertal Development Scale, BRIEF-P Behaviour Rating Inventory of Executive Function-
Parent form, BRIEF-T Behaviour Rating Inventory of Executive Function-Teacher form,
CPRS-L:R Conners’ Parent Rating Scales-Revised: Long, CTRS-L:R Conners’ Teacher Rating
Scales-Revised: Long, SRS=Social Responsiveness Scale, RRS = Ruminative Response Scale,
CAMM=Child and Adolescent Mindfulness Measure, BEQC=Body Experience
Questionnaire for Children, HSCP=Highly Sensitive Child Scale, ICU=Inventory of
Callous-Unemotional Traits, and SWAN=Strengths and Weakness of ADHD Symptoms
and Normal Behaviour
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[56][Cohen’s d effect size from 0.67 to 1.72 on
self-report BRIEF]. Further, in previous work using the
MYmind programme (unpublished data on a larger
non-randomised waitlist-controlled pilot in youth with
ADHD N = 195 families using parent-report BRIEF; see
also [55][Cohen’s d effect size from 0.0 to 1.8 on
parent-report BRIEF; 0.2 to 0.5 on teacher-rated BRIEF]),
a moderate effect on the BRIEF was found. Therefore
power calculations were based on a moderate effect size
of 0.4. Power analyses were run using the software
G*power 3.1 and based on the procedure by G. F. Borm,
J. Fransen and W. A. Lemmens [141]. Using this
method, the N per group is obtained from the N per
group for t-test multiplied by the design factor (D). The
design factor D = 1–r2, where r2 is the correlation be-
tween baseline and end of treatment on the BRIEF. We
determined r using the data of a normative sample over
a comparable time frame (six weeks): .86 [142]. As the
period between baseline and end of treatment is slightly
longer in this trial (around eleven weeks) the power ana-
lyses was conducted using a more conservative estimate
of r = .76, hence D = 1–.762 = .42.
Based on a power of 80%, a two-tailed test with α = .05
and an estimated effect size of 0.4, we need 100*.42 = 42
children in each group. Past studies conducted using the
MYmind programme (see section Intervention) using
non-randomised designs in youth with ADHD and ASD
found attrition rates from 5 to 15%. Therefore, we will
recruit a slightly larger sample (2xN = 50, total N = 100),
allowing room for attrition of around 15%.
Randomisation
Randomisation by means of minimisation [143] will be
performed after completion of the informed consent
forms. The treatment group that most strongly mini-
mises the imbalance between the two conditions is
chosen to allocate the patient. To balance possibly
prognostic factors across treatment groups, the follow-
ing procedure will be performed: first, a stratification
for age group is performed (elementary school or
secondary school). Then, block randomisation is per-
formed (with varying predefined block sizes), combined
with minimisation. The three minimisation factors are:
1) medication for ADHD at baseline (medication versus
no medication); 2) gender (male versus female); and 3)
age (younger (child: age 8–10 or adolescent: age 12–14)
versus older (child: age 10–12 or adolescent: age 14–
16)). Minimisation factors are of equal importance, and
block randomisation always wins over minimisation.
Concealment of allocation is guaranteed as the se-
quence behind the randomisation will be unknown by
the executing researcher.
Data collection, management analysis
As soon as the participant is enrolled, across all assess-
ments he or she will only be identifiable via a unique
pseudocode identifier to anonymise all data. A separ-
ate protected data-base will link the unique pseudo-
code to the participants’ names. Anonymous and
non-anonymous (e.g. informed consent forms) data
will be stored in separate password protected folders.
Video-data of the sessions will be transported with an
encrypted external hard disk and stored on a network
attached storage only accessible for the appointed re-
searchers. Questionnaire data will be collected and
stored with the online electronic data capture soft-
ware CASTOR EDC [144], which tracks and logs any
manual changes made to raw data and is fully Good
Clinical Practice (GCP) compliant. Quantitative data
that is first collected on paper (e.g. IQ test, diagnostic
interview) will be manually entered in CASTOR EDC
Table 2 Assessments for parents and time points
Assessments for parents Time points
Descriptives
Demographics T0
WAIS-III (Vocabulary and Block Design) T0
Self-rated K10 T0
Investigator-rated MINI T0
Secondary outcome measures
Self-rated self-control
BRIEF-A T0 T1 T2 T3
Computerised tasks of self-control T0 T1 T3
Psychological symptoms
Self-rated ADHD DSM-IV rating scale T0 T1 T2 T3
Self-rated AQ-10 T0 T1 T3
Self-rated DASS-21 T0 T1 T3
Self-rated RRS (Brooding) T0 T1 T3
Well-being
Self-rated WHO-5 T0 T1 T3
Self-rated MHC-SF T0 T1 T3
Mindful parenting
Self-rated IM-P T0 T1 T2 T3
Tertiary measures
Self-rated HSPS T0
Self-rated neuroticism (covariate for HSPS) T0
Self-rated self-compassion (exploratory items) T0 T1 T3
Note. T0 baseline, T1 end of treatment, T2 2-month follow-up, and
T3 6-month follow-up, WAIS-III=Wechsler Adult Intelligence Scale-Third Edition,
K10 = 10-item Kessler Psychological Distress Scale, MINI =Mini-International
Neuropsychiatric Interview, BRIEF-A = Behaviour Rating Inventory of Executive
Function-Adult version, AQ-10 = 10-item Short Autism-Spectrum Quotient,
RRS = Ruminative Response Scale, WHO-5 = 5-item World Health Organization-Five
Well-Being Index, MHC-SF =Mental Health Continuum-Short Form, DASS-21 = 21-
item Depression Anxiety Stress Scale, IM-P=Interpersonal Mindfulness in Parenting
Scale, and HSPS=Highly Sensitive Person Scale
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and the entry will be double checked by another re-
searcher. To prevent missing data, the force step
completion function will be used so informants can
only continue with the questionnaire when all items
are completed. When questionnaires are not com-
pleted within the expected period, participants/school
teachers will be sent online reminders. If no response
follows they will be contacted per telephone to dis-
cuss the absence of response and to motivate them to
complete the questionnaires, if necessary with conces-
sions (e.g. fewer questionnaires). In case participation
is discontinued, reasons will be noted and participants
will be asked to complete a drop-out questionnaire
with the main outcome measures (BRIEF-P, BRIEF-A,
CPRS and parental ADHD self-report). Clinically in-
formative results derived from child- and parent-rated
questionnaire data will be reported by the researchers
and sent to the involved participant after study par-
ticipation ends.
Statistical analyses
Data will be analysed and reported according to CON-
SORT guidelines. Baseline demographic and clinical
characteristics of the family MBI- and CAU-groups will
be compared to examine whether these have been dis-
tributed evenly across the two groups by the randomisa-
tion. The primary analyses will be aimed at comparing
results on the outcome measures at end of treatment be-
tween the family MBI and CAU condition, controlling
for baseline levels and possible other baseline differ-
ences between intervention and CAU groups. To test
our primary hypothesis that assignment to family
MBI (relative to CAU) will improve child self-control,
we will use ANCOVA with group condition (family
MBI versus CAU) as the primary independent vari-
able, and child self-control (continuous BRIEF-P
score) at end of treatment as the primary dependent
variable and child self-control at baseline as covariate.
Cohen’s d effect sizes will be calculated. Analyses will
be conducted both according to intention-to-treat
principle, and per-protocol on completers (family MBI
condition: child and parent attended > = 4 family MBI
sessions). Intention-to-treat analyses will be conducted
using available case analysis (not considering individ-
uals with missing data) as well as imputation, as
described in [145]. In case both parents participate in
the assessments, data of the parent with the most
complete dataset will be used for the ANCOVA, and
if both are complete, the sex of the parent (or age,
for same-sex parents) will determine which dataset
will be used so that the fathers:mothers ratio is most
similar across both study arms.
Secondary analyses, aimed at examining the consolida-
tion of treatment effects at follow-ups, will use
Fig. 1 Recruitment and study procedure Note. CAU=Care-As-Usual, MBI = Mindfulness-Based Intervention
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multilevel modelling with time point as repeated meas-
urement, following the approach described in [58].
Moreover, we will conduct a set of complementary ana-
lyses to derive prediction models for response to inter-
vention from baseline characteristics, and explore
interactions between child and parental outcomes.
Monitoring
A data protection officer independent from the re-
searcher will be assigned and monitors 1) the protec-
tion of the rights and well-being of the participants;
2) whether the reported research data is accurate and
completely verifiable in source documents; and 3)
whether the implementation of the research is con-
sistent with the approved protocol/amendment(s) at
that time, with GCP and the applicable legal require-
ments [146]. After including the first five participants,
all data will be monitored. That is, the accuracy and
completeness of all data (on item/trial level) per par-
ticipant will be checked. After including participant
five to ten, the completeness and accuracy of the data
on summary/scale level will be checked for all partici-
pants. Thereafter, data on summary/scale level will be
checked randomly for one in five participants. Out-
comes of this data monitoring will be summarised in
an overview and reported to all research personnel.
Based on previous studies on MBI for children and
Mindful Parenting, deterioration as a result of family
MBI is not expected. Therefore, no interim analysis will
be conducted. Adverse events (AEs) are defined as any
undesirable experience occurring to a participant dur-
ing the study, whether or not considered related to the
family MBI. All AEs reported spontaneously by the par-
ticipant or observed by the researcher or mindfulness
teachers will be recorded. All serious adverse events
(SAEs, resulting in death, life threatening, requiring
hospitalisation or other important medical events) will
be communicated to the principal and coordinating re-
searchers, who will report the SAEs to the accredited
ethics committee that approved the protocol, within fif-
teen days after the sponsor has first knowledge of the
SAE. SAEs that result in death or are life threatening
should be reported expedited. The expedited reporting
will occur not later than seven days after the respon-
sible researcher has first knowledge of the SAE.
Discussion
Self-control is a malleable determinant of success in
health, wealth, parenting, and avoiding crime [147].
Hence, improving self-control in children with
self-control deficits has an important impact on their life
and society. An example of a clinical population in
which targeting self-control in treatment is pressing is
youth with ADHD. ADHD is associated with adverse
outcomes including impediment on academic achieve-
ment, mental and substance use disorders, criminality,
and employment [148]. Current CAU for youth with
ADHD is often not sufficient in improving self-control.
Furthermore, CAU is generally not focused on mental
health and well-being of the parents, although this has
impact on the (treatment of the) child as well. ADHD
medication can have undesired side effects, is refused by
some families, compliance may be low, and improve-
ments do not last after medication discontinuation [35].
These shortcomings might be addressed by offering a
family-based MBI in addition to CAU. Self-regulation is
present at the basis of MBIs and work by cognitive neu-
roscientists demonstrates that brain structures and func-
tions that are involved in self-control are altered with
(mindfulness) meditation. There is strong evidence of
positive overall effects of MBIs in children as well as
adults [21, 149, 150]. However, studies investigating the
effects of MBIs on self-control in youth with ADHD
and/or their parents are scarce and there is a need for
methodologically stronger trials.
This protocol describes an adequately powered RCT
studying family MBI as an innovative
non-pharmacological approach in the treatment of youth
with ADHD. Children with comorbidities (e.g. ASD,
ODD, dyslexia) will be included which has the advantage
of increasing the representativeness of the sample for
the clinical ADHD population. Where previous studies
were uncontrolled or waitlist controlled, the current trial
allows comparison with a CAU control group. Actually
received CAU prior to and during study participation
will be registered in both the control and intervention
condition. The intervention is a manualised family MBI
(MYmind) for children and their parents given by well
trained experienced mindfulness teachers who will be
evaluated in terms of both their adherence to the proto-
col and competence. Another strength of the study is
that assessments will be done with different informants
allowing taking account of rater effects. Questionnaires
will not only be rated by self and parents, but also by
teachers who are not involved in the intervention. Next
to subjective ecologically valid questionnaires, objective
computerised tasks will be administered to explore ef-
fects on different aspects of self-control. Further, a broad
range of outcomes (e.g. neuropsychological functions,
clinical symptoms, positive health) will be assessed in
both the child and the parent. This not only allows
studying the effect of family MBI on child and parental
outcomes but also how they relate to each other. This
will increase our understanding of the influence of par-
ental symptoms, functioning and well-being on the child
and vice versa, and the possible role that MBI on a fam-
ily level may play in targeting child and/or parental
needs. In addition, follow-up assessments until six
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months after the end of treatment make it possible to in-
vestigate both the short- and long-term effectiveness of
the intervention. In a similar trial of an MBI in adults
with ADHD, significant effects on self-control assessed
with the BRIEF were only found at follow-up [58], as it
might take more time and practice before MBI results in
improvement of real-life self-control skills. Effects of
self-control are suggested to follow a continuum, there-
fore interventions that achieve even small improvements
in self-control for individuals, could shift outcomes
across the population as a whole in a positive direction
to impact health, wealth and crime rates [1]. Finally,
ADHD is one of several psychopathologies (e.g. ODD,
CD, addictions, mood- and anxiety disorders) that in-
volve self-control deficits. Hence, results of the proposed
RCT are in a cross-disorder perspective informative for a
broad clinical population.
Additional file
Additional file 1: Neurocognitive tests instructions. Neurocognitive test
instructions (translated from Dutch). (DOCX 18 kb)
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